Indication

Highly effective and well tolerated: the anti-inflammatory medication golimumab, known under the trade name Simponi®, is a valuable treatment option for patients with rheumatic diseases as well [...]

The intestinal bacterium Clostridium difficile is one of the most common causes of nosocomial infections. Patients whose intestinal flora is disrupted due to the use of antibiotics are [...]

As temperatures grow colder, the risk of catching the flu virus and spreading the infection among the population rises as well. But what makes the influenza virus so dangerous? For Virus [...]

More than five million people worldwide suffer from chronic inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis. World IBD Day on May 19 brings awareness to this [...]

Adalimumab (ADM) revolutionized the treatment of patients with inflammatory bowel diseases. Despite its therapeutic success, up to 40 % of patients do not respond to adalimumab induction [...]

Gastroenteritis, also known as the stomach flu, is one of the most frequent illnesses in humans worldwide. Often it is viruses that are responsible for the infection.

As allergies become more widespread, their diagnosis takes on an important role. For this purpose, laboratory tests that detect allergen-specific antibodies in the blood are indispensable tools. [...]

Patients with Crohn’s disease, ulcerative colitis or other inflammatory diseases are often treated with adalimumab. However, long-term therapy success is not always achieved. As a recent study [...]

RIDA®QUICK ADM Monitoring is a rapid test for adalimumab drug concentration monitoring which supports timely dose adjustments in clinical practice. A poster about the validation of the test was [...]

Clostridium difficile is one of the most frequent pathogens in nosocomial infections – but in spite of this many people have never heard of it. Since November is officially “Clostridium [...]